Article
DNA methylation status of key cell-cycle regulators such as CDKNA2/p16 and CCNA1 correlates with treatment response to doxorubicin and 5-fluorouracil in locally advanced breast tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Dec 2014
Klajic Jovana, Busato Florence, Edvardsen Hege, Touleimat Nizar, Fleischer Thomas, Bukholm Ida, Børresen-Dale Anne-Lise, Lønning Per Eystein, Tost Jörg, Kristensen Vessela N
Abstract excerpt
PURPOSE: To explore alterations in gene promoter methylation as a potential cause of acquired drug resistance to doxorubicin or combined treatment with 5-fluorouracil and mitomycin C in human breast cancers. EXPERIMENTAL DESIGN: Paired tumor samples from locally advanced breast cancer patients treated with doxorubicin and 5-fluorouracil-mitomycin C were used in the genome-wide DNA methylation analysis as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
